NCT07876102

Brief Summary

Pilot feasibility and acceptability trial of the SMART-Y intervention in a small group of adolescents (n=18), age 14-17

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Nov 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 15, 2026

Completed
17 days until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

October 15, 2026

Status Verified

October 1, 2026

Enrollment Period

10 months

First QC Date

October 8, 2026

Last Update Submit

October 8, 2026

Conditions

Keywords

EpilepsySelf-ManagementAdolescentsSMARTFeasibility and AcceptabilityPilot

Outcome Measures

Primary Outcomes (3)

  • Feasibility 1 - Session Attendance Rate

    Percentage of scheduled intervention sessions attended during the 12-week intervention period. Each participant will be scheduled to attend 8 weekly intervention sessions; therefore, the total number of scheduled sessions will be calculated as the number of participants enrolled multiplied by 8 sessions.

    8 weeks

  • Feasibility 2 - Intervention Sessions Retention

    Proportion of participants who attended 75% of the sessions. Retention to sessions will be calculated as the number of participants attending at least 6 of the 8 scheduled intervention sessions divided by the total number of participants enrolled.

    8 weeks

  • Feasibility 3 - Assessment Retention

    Percentage of participants who complete both the baseline and 12-week assessments. Assessment retention will be calculated as the number of participants completing both assessments divided by the number of participants enrolled.

    12 weeks

Secondary Outcomes (4)

  • Change in 30-Day Seizure Count

    Baseline, 12 weeks

  • Change in Negative Health Events (NHE) Total Score

    Baseline, 12 weeks

  • Change in PedsQL Epilepsy Module Standard Version Total Score

    Baseline, 12 weeks

  • Change in PedsQL Epilepsy Module Acute Version Total Score

    Baseline, 12 weeks

Study Arms (1)

Experimental: [SMART-Y]

EXPERIMENTAL
Behavioral: SMART-Y

Interventions

SMART-YBEHAVIORAL

SMART-Y is a youth-focused adaptation of SMART ( Self-MAnagement for people with epilepsy and a histoRy of negative health evenTs) developed for adolescents transitioning into adulthood. SMART is a remotely delivered, real-time group intervention that supports epilepsy self-management among individuals with recent epilepsy-related complications. The program emphasizes seizure control, lifestyle management, and emotional health.

Experimental: [SMART-Y]

Eligibility Criteria

Age14 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 14-17
  • Diagnosed with epilepsy, per clinician or chart diagnosis
  • Has parent/guardian that is able/willing to consent (parent does not have to also participate, just has to consent to the youth's participation)
  • Speaks English

You may not qualify if:

  • Comorbid Dx: moderate-severe intellectual disability
  • Unable to assent to the study
  • Unable to meaningfully participate in the intervention sessions or assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Sajatovic M, Tatsuoka C, Welter E, Perzynski AT, Colon-Zimmermann K, Van Doren JR, Bukach A, Lawless ME, Ryan ER, Sturniolo K, Lhatoo S. Targeted Self-Management of Epilepsy and Mental Illness for individuals with epilepsy and psychiatric comorbidity. Epilepsy Behav. 2016 Nov;64(Pt A):152-159. doi: 10.1016/j.yebeh.2016.08.012. Epub 2016 Oct 12.

    PMID: 27743547BACKGROUND
  • Sajatovic M, Jobst BC, Shegog R, Bamps YA, Begley CE, Fraser RT, Johnson EK, Pandey DK, Quarells RC, Scal P, Spruill TM, Thompson NJ, Kobau R. The Managing Epilepsy Well Network:: Advancing Epilepsy Self-Management. Am J Prev Med. 2017 Mar;52(3 Suppl 3):S241-S245. doi: 10.1016/j.amepre.2016.07.026.

    PMID: 28215372BACKGROUND
  • Sajatovic M, Colon-Zimmermann K, Kahriman M, Fuentes-Casiano E, Liu H, Tatsuoka C, Cassidy KA, Lhatoo S, Einstadter D, Chen P. A 6-month prospective randomized controlled trial of remotely delivered group format epilepsy self-management versus waitlist control for high-risk people with epilepsy. Epilepsia. 2018 Sep;59(9):1684-1695. doi: 10.1111/epi.14527. Epub 2018 Aug 10.

    PMID: 30098003BACKGROUND

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Molly K McVoy, MD

    University Hospitals Cleveland Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician

Study Record Dates

First Submitted

October 8, 2026

First Posted

October 15, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

October 15, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

This is an internal pilot study.